Abstract
Protein tyrosine phosphatase 1B (PTP1B) is a prototype non receptor cytoplasmic PTPase enzyme that has been implicated in regulation of insulin and leptin signaling pathways. Studies on PTP1B knockout mice and PTP1B antisense treated mice suggested that inhibition of PTP1B would be an effective strategy for the treatment of type II diabetes and obesity. Here we report the X-ray structure of PTP1B in complex with compound IN1834-146C (PDB ID 4I8N). The crystals belong to P3121 space group with cell dimensions (a = b = 87.89 Å, c = 103.68 Å) diffracted to 2.5 Å. The crystal structure contained one molecule of protein in the asymmetric unit and was solved by molecular replacement method. The compound engages both catalytic site and allosteric sites of PTP1B protein. We described the molecular interaction of the compound with the active site residues of PTP1B in this crystal structure report.
Keywords: Protein tyrosine phosphatases (PTP1B), T cell PTP (TCPTP) and X-Ray Crystallography.
Protein & Peptide Letters
Title:X-Ray Structure of PTP1B in Complex with a New PTP1B Inhibitor
Volume: 21 Issue: 1
Author(s): M.V.V.V. Sekhar reddy, Chakshumathi Ghadiyaram, Sunil Kumar Panigrahi, Narasimha Rao Krishnamurthy, Subramanya Hosahalli, Arun P. Chandrasekharappa, Deepankar Manna, Sangamesh E. Badiger, Pramod K. Dubey and Lakshmi Narasu Mangamoori
Affiliation:
Keywords: Protein tyrosine phosphatases (PTP1B), T cell PTP (TCPTP) and X-Ray Crystallography.
Abstract: Protein tyrosine phosphatase 1B (PTP1B) is a prototype non receptor cytoplasmic PTPase enzyme that has been implicated in regulation of insulin and leptin signaling pathways. Studies on PTP1B knockout mice and PTP1B antisense treated mice suggested that inhibition of PTP1B would be an effective strategy for the treatment of type II diabetes and obesity. Here we report the X-ray structure of PTP1B in complex with compound IN1834-146C (PDB ID 4I8N). The crystals belong to P3121 space group with cell dimensions (a = b = 87.89 Å, c = 103.68 Å) diffracted to 2.5 Å. The crystal structure contained one molecule of protein in the asymmetric unit and was solved by molecular replacement method. The compound engages both catalytic site and allosteric sites of PTP1B protein. We described the molecular interaction of the compound with the active site residues of PTP1B in this crystal structure report.
Export Options
About this article
Cite this article as:
reddy Sekhar M.V.V.V., Ghadiyaram Chakshumathi, Panigrahi Kumar Sunil, Krishnamurthy Rao Narasimha, Hosahalli Subramanya, Chandrasekharappa P. Arun, Manna Deepankar, Badiger E. Sangamesh, Dubey K. Pramod and Mangamoori Narasu Lakshmi, X-Ray Structure of PTP1B in Complex with a New PTP1B Inhibitor, Protein & Peptide Letters 2014; 21 (1) . https://dx.doi.org/10.2174/09298665113209990089
DOI https://dx.doi.org/10.2174/09298665113209990089 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Managing Expectations in the Transition to Proof of Concept Studies
Reviews on Recent Clinical Trials Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
Current Drug Metabolism Molecular and Cellular Activities of Vitamin E Analogues
Mini-Reviews in Medicinal Chemistry Subject Index to Volume 3
Current Gene Therapy The Complications of Bariatric Surgery Patients with Type 2 Diabetes in the World: A Systematic Review and Meta-Analysis
Current Diabetes Reviews Inhibitors of Aldo-Keto Reductases AKR1C1-AKR1C4
Current Medicinal Chemistry Corrigendum
Current Pharmaceutical Design Recent Advances on the Application of Graphene Quantum Dots in Energy Storage
Recent Patents on Nanotechnology Emergency Contraception: Current Methods, Usages and Issues
Current Women`s Health Reviews Peptide5 Attenuates rtPA Related Brain Microvascular Endothelial Cells Reperfusion Injury via the Wnt/β-Catenin Signalling Pathway
Current Neurovascular Research Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma
Current Clinical Pharmacology Sports Medicine Applications of Platelet Rich Plasma
Current Pharmaceutical Biotechnology Impact of Cerebral Oxygen Saturation Monitoring on Short-term Neurodevelopmental Outcomes in Neonates with Encephalopathy - A Prospective Cohort Study
Current Pediatric Reviews Ocular Neovascularization: Genomic Implications
Current Genomics ICT for Telemedicine and Health Care Innovation
Recent Patents on Biomedical Engineering (Discontinued) Strategies for Diabetes Prevention Before and After Pregnancy in Women with GDM
Current Diabetes Reviews Novel Plant Sterol and Stanol Derivatives with Beneficial Properties:Efficacy and Safety
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Structure-Based Virtual Ligand Screening: Recent Success Stories
Combinatorial Chemistry & High Throughput Screening Nanocarriers for Gene Delivery - Polymer Structure, Targeting Ligands and Controlled-Release Devices
Current Nanoscience Preparation of Knockout Extract for Determination of Really Active Compound Using MAb
Current Drug Discovery Technologies